Responses
Regular and Young Investigator Award Abstracts
Combination Immunotherapies
797 Genomic and transcriptomic profiles associated with response to eribulin and nivolumab combination in HER-2 negative metastatic breast cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.
